SCHEMBL16826097

SCHEMBL16826097

CSC(=NC#N)N1CCN(C(=O)COc2ccc(Br)cc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
MAPT P10636 6/20 0.53
NPSR1 Q6W5P4 1/20 0.53
GPR183 P32249 1/20 0.53
PPARG P37231 1/20 0.52
NR2E3 Q9Y5X4 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
POLB P06746 1/20 0.51
KDM4E B2RXH2 2/20 0.50
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.47
CHIA Q9BZP6 1/20 0.47
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826096 1.00 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AMAPTNPSR1
SCHEMBL16826357 0.89 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AMAPTGPR183
SCHEMBL16826162 0.89 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AMAPTGPR183
SCHEMBL16825902 0.88 MEN1 (0.62) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL16825901 0.88 MEN1 (0.62) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL16825670 0.84 NPC1 (0.60) ALDH1A1MEN1KMT2AMAPTGPR183
SCHEMBL16825667 0.84 NPC1 (0.60) ALDH1A1MEN1KMT2AMAPTGPR183
SCHEMBL16826342 0.82 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL16825783 0.82 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL16826085 0.80 MEN1 (0.54) ALDH1A1MEN1KMT2AMAPTGPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082805-B1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INST FOR DRUG DISCOVERY LLC (US) 2020-02-05 EP disclosed
EP-3082805-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME The Institute For Drug Delivery (US) 2016-10-26 EP disclosed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 US disclosed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME CMA1, CHIA, AADAC ALDH1A1 1006/4885MEN1 2231/4885KMT2A 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.